And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes

(MedPage Today) -- PHILADELPHIA -- An enormous swath of Americans can be expected to get secondary cardiovascular prevention benefits from weekly semaglutide (Wegovy) injections based on the SELECT trial. Even in the absence of diabetes, overweight...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news